Form 4: Liquidia CEO Roger Jeffs Reports Routine Stock Transactions for Tax Coverage

Liquidia Corp's CEO, Roger Jeffs, reported the conversion of performance stock units and a subsequent sale of common stock to cover tax obligations, as detailed in a recent SEC Form 4 filing.

Summary

• Roger Jeffs, Chief Executive Officer and Director of Liquidia Corp, reported transactions involving company common stock.
• On July 11, 2025, 13,833 Performance Stock Units (PSUs) converted into common stock on a one-for-one basis.
• On July 14, 2025, 20,252 shares of common stock were sold at a price of $14.28 per share.
• The sale was executed pursuant to a Rule 10b5-1 plan adopted by Roger Jeffs on December 15, 2023.
• The purpose of the sale was to cover tax liabilities associated with the settlement of Restricted Stock Units (RSUs) and PSUs initially granted on January 11, 2023, and January 11, 2024.
• Following these transactions, Roger Jeffs directly beneficially owns 1,038,560 shares of common stock.
• Direct ownership includes 108,562 unvested RSUs from a January 11, 2023 grant, 138,336 unvested RSUs from a January 11, 2024 grant, 229,327 unvested RSUs from a January 11, 2025 grant, and 9,856 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
• Roger Jeffs also indirectly owns 46,595 shares through the Roger A. Jeffs Living Trust and 1,541,667 shares through Serendipity BioPharma LLC.

Sentiment

Score: 5

Explanation: The document is a routine Form 4 filing detailing insider stock transactions, specifically a sale for tax purposes under a pre-arranged plan. It contains no positive or negative operational news about the company, thus maintaining a neutral sentiment.

Positives

• The sale of shares was conducted under a pre-arranged Rule 10b5-1 plan, which indicates a structured and pre-planned approach to stock transactions, reducing concerns about opportunistic selling.
• The stated reason for the sale was to cover tax obligations associated with the vesting of equity awards, which is a common and expected practice for executives receiving stock-based compensation.

Negatives

• A sale of 20,252 shares by the CEO, even for tax purposes, results in a reduction of his direct beneficial ownership in the company.

Risks

• No specific new risks are introduced or highlighted in this Form 4 filing beyond the inherent risks of holding company stock and the tax liabilities associated with equity compensation.

Future Outlook

The document does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on insider stock transactions.

Management Comments

• Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
• These shares were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023 and January 11, 2024.

Industry Context

This Form 4 filing is a routine disclosure of insider stock transactions, common across all publicly traded industries. It reflects an executive's management of their equity compensation and tax obligations, rather than a specific industry trend or competitive action.

Comparison to Industry Standards

• The use of a Rule 10b5-1 plan for stock sales is a standard practice among executives in publicly traded companies, including those in the biotechnology and pharmaceutical sectors, to mitigate accusations of insider trading.
• Selling shares to cover tax obligations upon the vesting or exercise of equity awards (like RSUs and PSUs) is a common and expected financial management strategy for executives across all industries.

Stakeholder Impact

• Shareholders: The sale of shares by the CEO, even for tax purposes, slightly reduces the CEO's direct ownership percentage. However, the pre-planned nature of the sale under Rule 10b5-1 provides transparency and is generally viewed as a routine financial management activity rather than a signal of lack of confidence.

Next Steps

• Continued vesting of remaining PSUs granted on January 11, 2024, ratably on a quarterly basis over three years after January 11, 2025.
• Continued vesting of unvested RSUs granted on January 11, 2023, January 11, 2024, and January 11, 2025, according to their respective schedules.

Key Dates

Recommendation

Keywords

Liquidia Corp, LQDA, Roger Jeffs, SEC Form 4, Insider Trading, Stock Sale, Performance Stock Units, Restricted Stock Units, Rule 10b5-1 Plan, Executive Compensation, Tax Obligations